TAT: 4-8 weeks price: $635.00
Analysis MUTYH gene (MUTYH-Associated Polyposis) method(s): ◦ Sequencing, Capillary (Sanger) Academic Medical Centre, University of Amsterdam, DNA Diagnostics Laboratory - Amsterdam, Netherlands |
CancerNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
BreastNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
ColoNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
MUTYH-Associated Polyposis Test method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
Breast and Ovarian Cancer Test method(s): ◦ Genotyping (Microarray, Beads, etc.) ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
MUTYH-Associated Polyposis Test method(s): ◦ Genotyping (Microarray, Beads, etc.) ◦ Sequencing, Capillary (Sanger) Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
MUTYH Gene Analysis method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) Myriad Genetic Laboratories, Inc., Myriad Genetic Laboratories - Salt Lake City, UT, USA |
MUTYH-Associated Polyposis (MAP), MUTYH (MYH), Sequencing method(s): ◦ Sequencing, Capillary (Sanger) Oregon Health & Science University, Knight Diagnostic Laboratories - Molecular Diagnostic Center - Portland, OR, USA |
iGene Cancer Panel method(s): ◦ Sequencing, Next Gen ApolloGen, Inc. - Irvine, CA, USA |
iGene Comprehensive Panel (Cancer, Cardiac, Drug Sensitivity) method(s): ◦ Sequencing, Next Gen ApolloGen, Inc. - Irvine, CA, USA |
Colorectal Adenomatous Polyposis Test, AR (the MUTYH gene-selected fragment) method(s): ◦ Sequencing, Capillary (Sanger) GENESIS Center for Medical Genetics, Laboratory of Molecular Genetics - Poznan, Poland |
MYH Associated Polyposis SEQ-KFM method(s): ◦ Sequencing, Capillary (Sanger) Baylor Miraca Genetics Laboratories - Houston, TX, USA |
MYH Panel method(s): ◦ Genotyping (Microarray, Beads, etc.) Baylor Miraca Genetics Laboratories - Houston, TX, USA |
MYH Associated Polyposis SEQ method(s): ◦ Sequencing, Capillary (Sanger) Baylor Miraca Genetics Laboratories - Houston, TX, USA |
MUTYH-Associated Polyposis method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) MVZ Dortmund Dr. Eberhard and Partner - Dortmund, Germany |
Hereditary Cancer Syndrome: Sequencing Panel method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
MUTYH-Associated Polyposis: MUTYH Gene Sequencing method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
MUTYH-Associated Polyposis: MUTYH Gene Deletion/Duplication method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
MUTYH-Associated Polyposis: MUTYH Common Mutation Panel method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Hereditary Colon Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Mayo Clinic - Minnesota, Molecular Genetics Laboratory - Rochester, MN, USA |
MYH Gene Analysis for Multiple Adenoma method(s): ◦ Genotyping (Microarray, Beads, etc.) Mayo Clinic - Minnesota, Molecular Genetics Laboratory - Rochester, MN, USA |
Sanger sequencing of the MUTYH gene method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Capillary (Sanger) Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 3 genes: APC, AXIN2, MUTYH method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 3 genes: APC, AXIN2, MUTYH + APC by MLPA method(s): ◦ Del/Dup (CNV) ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Frequent mutations in the MUTYH gene method(s): ◦ Sequencing, Capillary (Sanger) ◦ Mutation Scanning of Select Exons Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 3 genes: NUDT1, OGG1, MUTYH method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Detection of large deletions and/or duplications i n the MUTYH gene by MLPA method(s): ◦ Del/Dup (CNV) Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 21 genes: APC, ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, ERCC4,HOXB13, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS1, PTEN, RAD51C, RAD51D, STK11, TP53, XRCC2 and complementary Sanger sequencing of PTEN gene method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 11 genes: APC, BRCA1, BRCA2, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS1, TP53. method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Analysis of Pilomatrixoma method(s): ◦ Sequencing, Capillary (Sanger) Center for Human Genetics and Laboratory Medicine Martinsried, Molecular Genetics - Martinsried, Germany |
ColoTrue method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Pathway Genomics Corporation - San Diego, CA, USA |
Colorectal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen GeneDx - Gaithersburg, MD, USA |
Comprehensive Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen GeneDx - Gaithersburg, MD, USA |
Endometrial Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen GeneDx - Gaithersburg, MD, USA |
Lynch/Colorectal High Risk Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen GeneDx - Gaithersburg, MD, USA |
Polyposis Syndromes method(s): ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
Familial Adenomatous Polyposis method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) Laboratories AGEL a.s. - Novy Jicin, Czech Republic |
Familial Adenomatous Polyposis Panel: (APC) Sequencing and Deletion/Duplication, (MUTYH) 2 Mutations method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Gastrointestinal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 16 Genes method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
MUTYH-Associated Polyposis (MUTYH) 2 Mutations method(s): ◦ Genotyping (Microarray, Beads, etc.) ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
MUTYH-Associated Polyposis (MUTYH) 2 Mutations with Reflex to Sequencing method(s): ◦ Genotyping (Microarray, Beads, etc.) ◦ Sequencing, Capillary (Sanger) ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
MUTYH-Associated Polyposis (MUTYH) Sequencing method(s): ◦ Sequencing, Capillary (Sanger) ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Hereditary Cancer Panel 170 PLUS method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Hereditary Cancer Panel 'For Him' method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Hereditary Cancer Panel 'For Her' method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Hereditary Colon Cancer, Panel Massive Sequencing (NGS) 15 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Mitochondrial Disorders Panel method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Familial adenomatous polyposis 2 (sequence analysis of MUTYH gene) method(s): ◦ Sequencing, Capillary (Sanger) CGC Genetics - Porto, Portugal |
Familial adenomatous polyposis 2 (Y179C and G396D mutations on MUTYH gene) method(s): ◦ Sequencing, Capillary (Sanger) CGC Genetics - Porto, Portugal |
Breast cancer - 18 genes (NGS panel for ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, ERCC4, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11 and TP53 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 94 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
High/Moderate Risk Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen GeneDx - Gaithersburg, MD, USA |
CancerNext - Expanded method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
OvaNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
Hereditary Non-Polyposis Colorectal Cancer method(s): ◦ Sequencing, Next Gen Amplexa Genetics A/S, Amplexa Genetics, Amplexa - Odense C, Denmark |
Oncology, Panel method(s): ◦ Sequencing, Next Gen GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Colon Cancer method(s): ◦ Sequencing, Next Gen GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Adenomatous Polyposis, Familial 2 (FAP2): MYH gene sequence analysis method(s): ◦ Sequencing, Capillary (Sanger) GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Comprehensive COLARIS method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) Myriad Genetic Laboratories, Inc., Myriad Genetic Laboratories - Salt Lake City, UT, USA |
Comprehensive COLARIS AP method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) Myriad Genetic Laboratories, Inc., Myriad Genetic Laboratories - Salt Lake City, UT, USA |
Breast, Colon and Ovarian Hereditary Cancer, Panel Massive Sequencing (NGS) 23 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Hereditary Cancer Syndromes, Comprehensive Diagnostics method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Polyposis Coli method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Colorectal Cancer method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Thyroid Cancer method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Severe Recessive Childhood Diseases method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
MUTYH-Associated Polyposis Test method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Colon Cancer Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Breast and Ovarian Cancer - extended Diagnostic Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes method(s): ◦ Microarray (CGH-Oligo, SNP, BAC) ◦ Sequencing, Next Gen ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes method(s): ◦ Microarray (CGH-Oligo, SNP, BAC) ◦ Sequencing, Next Gen ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Somatic Tumor Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Colon Cancer- Polyposis Coli Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
OncoRisk (NGS panel for 49 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Familial adenomatous polyposis (deletion/duplication analysis of MUTYH gene) method(s): ◦ Del/Dup (CNV) CGC Genetics - Porto, Portugal |
Single gene testing MUTYH method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) CeGaT GmbH - Tübingen, Germany |
Gastrointestinal and Colorectal Cancer: Sequencing Panel method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Gastrointestinal and Colorectal Cancer: Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
High Risk Colorectal Cancer: Sequencing Panel method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
High Risk Colorectal Cancer: Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
MUTYH-Associated Polyposis: MUTYH Common Mutation Panel method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
MUTYH-Associated Polyposis: MUTYH Gene Deletion/Duplication method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
MUTYH-Associated Polyposis: MUTYH Gene Sequencing method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
OncoRisk Plus (NGS panel for 89 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Myriad myRisk Hereditary Cancer method(s): ◦ Sequencing, Next Gen Myriad Genetic Laboratories, Inc., Myriad Genetic Laboratories - Salt Lake City, UT, USA |
Familial Adenomatosis Polyposis method(s): ◦ Del/Dup (CNV) ◦ Mutation Scanning of Select Exons ◦ Sequencing, Next Gen GeneKor Medical S.A. - Athens, Greece |
Hereditary Colon and Endometrial Cancer-ColoNGS method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen GeneKor Medical S.A. - Athens, Greece |
Gastric Cancer method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Familial Adenomatous Polyposis, Panel Massive Sequencing (NGS) APC and MUTYH Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Familial Adenomatous Polyposis Type 2, Deletions-Duplications (MLPA) MUTYH Gene method(s): ◦ Del/Dup (CNV) Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Cancer Predisposition method(s): ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
TAT: 12-16 weeks price: $1,880.00
Colorectal Cancer NGS panel (20 genes) method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Academic Medical Centre, University of Amsterdam, DNA Diagnostics Laboratory - Amsterdam, Netherlands |
Focus Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
MUTYH method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Nuclear-Mito NGS Panel method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Fulgent Diagnostics - Temple City, CA, USA |
Colorectal Cancer Focus Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Comprehensive Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Colorectal Cancer Comprehensive Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Familial Adenomatous Polyposis: MUTYH gene method(s): ◦ Sequencing, Capillary (Sanger) GenoMed-Diagnosticos de Medicina Molecular, SA - Lisboa, Portugal |
Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen University of Chicago, Genetic Services Laboratory - Chicago, IL, USA |
Comprehensive Hereditary Breast-Ovarian Cancer Panel method(s): ◦ Sequencing, Next Gen NeoGenomics Laboratories - Fort Myers, FL, USA |
Adenomatous Polyposis (APC and MUTYH Gene Sequence and Deletion/ Duplication Analyses) method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
CustomNext-Cancer method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
TAT: 3-4 weeks price: $690.00
MUTYH Associated Polyposis (MAP) Syndrome via the MUTYH Gene method(s): ◦ Del/Dup (CNV) PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks price: $1,190.00
Colorectal Cancer Sequencing And Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks price: $1,190.00
Hereditary Breast and Ovarian Cancer Syndrome - HBOC EXPANDED Sequencing and Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 2-3 weeks price: $790.00
MUTYH Associated Polyposis (MAP) Syndrome via the MUTYH Gene method(s): ◦ Sequencing, Capillary (Sanger) PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks price: $1,390.00
Cancer Sequencing and Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3 weeks price: $795.00
Otogenetics Hereditary Cancers (Breast, Gyn, GI) method(s): ◦ Sequencing, Next Gen Otogenetics Corporation - Atlanta, GA, USA |
Familial Adenomatous Polyposis, Panel Massive Sequencing (NGS) 7 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Inherited Cancer Screen method(s): ◦ Sequencing, Next Gen Counsyl, Inc., Counsyl - South San Francisco, CA, USA |
Adenomatous polyposis (Familiäre adenomatöse Polypose) method(s): ◦ Sequencing, Capillary (Sanger) Praxis fuer Humangenetik Wien - Vienna, Austria |
Gastric Cancer (Magenkarzinom) method(s): ◦ Sequencing, Next Gen Praxis fuer Humangenetik Wien - Vienna, Austria |
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Familial adenomatous polyposis type 2 method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Centogene AG, Rare Disease Company - Rostock, Germany |
Breast ovarian cancer panel PLUS method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
CentoCancer panel method(s): ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
CentoColon extended panel method(s): ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
Breast and Ovarian Cancer 21 Gene Panel method(s): ◦ Sequencing, Next Gen Genomic Research Center, Shahid Beheshti University of Medical Sciences - Tehran, Iran, Islamic Republic of |
Hereditary Colorectal Cancer High Risk Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen University of Chicago, Genetic Services Laboratory - Chicago, IL, USA |
Colorectal Polyposis Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen University of Chicago, Genetic Services Laboratory - Chicago, IL, USA |
Comprehensive Hereditary Colorectal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen University of Chicago, Genetic Services Laboratory - Chicago, IL, USA |
CentoMito™ Comprehensive method(s): ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
Colon cancer with polyps panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
TAT: 1-3 weeks price: $1,500.00
Invitae Breast and Gyn Cancers Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae MUTYH-Associated Polyposis Syndrome Test method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Breast Cancer Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Colorectal Cancer Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Multi-Cancer Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI) method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Colorectal Cancer Guidelines-Based Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
Hereditary Colorectal/Gastrointestinal Cancer method(s): ◦ Sequencing, Next Gen Baylor Miraca Genetics Laboratories - Houston, TX, USA |
Comprehensive Hereditary Cancer Panel method(s): ◦ Sequencing, Next Gen Baylor Miraca Genetics Laboratories - Houston, TX, USA |
High Risk Hereditary Colorectal Cancer Panel method(s): ◦ Sequencing, Next Gen Baylor Miraca Genetics Laboratories - Houston, TX, USA |
Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Hereditary Colorectal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Hereditary Gastrointestinal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Hereditary Colorectal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Hereditary Gastrointestinal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Phosphorus Common / High-Risk Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Pan Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Breast Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Colorectal Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |